Linked e-resources

Details

Evidence, politics, and medical care technology
Evolving public- and private-payer approaches to evidence and health technology assessment
Mammography screening: vested interests and polarization
When medicare said no for amyloid pet imaging
Placing a value on cure: lessons from the new generation of hepatitis C drugs
Avastin and the politics of accelerated approval
The path to the clinic for stem cell and other regenerative medicine interventions
Conclusion: the 21st century cures act and the future of health technology assessment.

Browse Subjects

Show more subjects...

Statistics

from
to
Export